Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...
PREDAPT Trial Validates RNA-Based Predictive Biomarker Across 1400+ Patients to Inform Immunotherapy Treatment in NSCLC ST. LOUIS, December 17, 2025--(BUSINESS WIRE)--Cofactor Genomics, a leader in ...
A number of tumor and host characteristics have been found useful in predicting the risk of recurrence and the chance of death from breast cancer following primary surgery. Traditional prognostic ...
Renovaro Inc. has announced a binding letter of intent to acquire Predictive Oncology in an all-stock transaction, enhancing its cancer diagnostics and therapeutics capabilities. This acquisition ...
The firm will retrospectively analyze data from more than 1,100 breast cancer patients treated in Unicancer's clinical trials.
Predictive Oncology Inc. has announced a binding letter of intent to be acquired by Renovaro, Inc. in exchange for preferred stock. Both companies focus on enhancing cancer patient outcomes through AI ...
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Turbine, a predictive simulation company that is building a platform for interpreting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback